Questions: Bacterial Typing and Identification Techniques
5 questions to test your understanding
Score: 0 / 5
Question 1 Multiple Choice
Three patients in a hospital develop Klebsiella pneumoniae infections in the same week. Clinicians want to know whether they share the same strain (suggesting hospital transmission) or acquired different strains independently. Which method is most appropriate for answering this question?
ABiochemical testing (API strips) to compare the metabolic profiles of the three isolates
B16S rRNA gene sequencing to confirm that all three are K. pneumoniae
CGram staining and colony morphology comparison under a microscope
DWhole-genome sequencing or cgMLST to compare isolates at single-nucleotide resolution and reconstruct potential transmission chains
This is a typing question, not an identification question. All three isolates are already known to be K. pneumoniae — species identity is established. The epidemiological question is whether they share a common clonal origin, requiring resolution below the species level. Biochemical tests (option A) and Gram staining (option C) lack the discriminatory power to distinguish strains within a species. 16S rRNA (option B) is useful for identification but cannot reliably differentiate closely related strains. WGS/cgMLST provides single-nucleotide differences between isolates, enabling epidemiologists to assess whether they are too similar to have arisen independently — the current gold standard for outbreak investigation.
Question 2 Multiple Choice
MALDI-TOF mass spectrometry identifies a clinical isolate as Staphylococcus aureus in seconds. For infection control purposes, this result is:
ASufficient — MALDI-TOF provides species and strain information needed to investigate potential transmission
BNecessary but not sufficient — species identity is established, but strain-level typing is still required to determine whether cases are epidemiologically linked
CInsufficient even for species identification — MALDI-TOF is unreliable for Gram-positive organisms
DMore information than required — a positive Gram stain would establish sufficient clinical information
MALDI-TOF is excellent for rapid, accurate species identification — one of its great clinical advantages. But knowing 'this is S. aureus' does not tell you whether two patients' S. aureus isolates are the same strain. S. aureus is ubiquitous; independent acquisitions of different strains are common. For outbreak investigation, you need to know whether isolates are clonally related — a question of typing, not identification. MALDI-TOF spectral fingerprints reflect conserved housekeeping proteins and cannot resolve sub-species strain differences. Subsequent PFGE, MLST, or WGS is required for epidemiological linkage.
Question 3 True / False
A single biochemical test result — such as a positive catalase reaction — is sufficient to definitively identify an unknown bacterial species.
TTrue
FFalse
Answer: False
A single test provides a single data point that narrows but rarely establishes identity. Many unrelated species share catalase-positive results (e.g., all staphylococci and most aerobic Gram-negatives). Definitive identification requires a convergence of multiple independent lines of evidence — morphology, multiple biochemical tests, and ideally molecular confirmation. This is why clinical systems like API strips run 20+ tests simultaneously, producing a numerical profile matched against a database. Modern best practice pairs phenotypic testing with MALDI-TOF or molecular methods, recognizing that any individual phenotypic trait is too widely shared to serve as a definitive identifier alone.
Question 4 True / False
The distinction between bacterial identification (what species?) and typing (which strain?) matters clinically because typing is needed to determine whether patients in a hospital share a common source of infection.
TTrue
FFalse
Answer: True
This distinction structures all of clinical microbiology diagnostics. Identification answers the question a treating physician needs first: 'what organism am I treating, and what antibiotics are likely to work?' Typing answers the question an infection control epidemiologist needs: 'are these cases connected — is there a common source, a contaminated piece of equipment, or a carrier transmitting within the facility?' The same species can cause both sporadic unrelated infections and clonal outbreaks; only typing can distinguish these scenarios. Whole-genome sequencing has made this distinction increasingly precise — two isolates differing by zero to five single-nucleotide variants are considered epidemiologically linked in many outbreak investigations.
Question 5 Short Answer
Why is a single phenotypic test insufficient for definitive bacterial identification, and what approach does modern clinical practice use instead?
Think about your answer, then reveal below.
Model answer: A single phenotypic test measures one aspect of an organism's biology — one enzyme, one metabolic capability, one structural feature — and many unrelated organisms share any given characteristic. No single phenotypic trait is both universal to a species and absent from all others. Modern clinical identification relies on convergent evidence: multiple biochemical tests run simultaneously (API strip, Vitek panel) generating a profile compared against a reference database, combined with MALDI-TOF mass spectrometry, which generates a protein spectral fingerprint matched against thousands of reference spectra. For cases where species-level confidence remains insufficient, 16S rRNA sequencing provides phylogenetic placement. Each method addresses different aspects of identity; their combination raises confidence from plausible to definitive.
The practical implication is that diagnostic algorithms are intentionally multi-layered. Each method has characteristic strengths and failure modes: MALDI-TOF is fast and accurate for common organisms but fails for rare or poorly represented species; 16S rRNA resolves phylogenetic placement but not strain-level differences; biochemical profiles work for species with distinct metabolic signatures but fail for metabolically similar organisms. Using multiple independent methods catches the cases where any single method would fail.